Home » Endocyte Moves Operations to Purdue Technology Center
Endocyte Moves Operations to Purdue Technology Center
Endocyte recently held an open house to showcase its new, state-of-the-art facilities in the Purdue Research Park's newly expanded flagship incubator. The biotechnology firm, which develops receptor-targeted therapeutics for the treatment of cancer and autoimmune diseases, now holds the anchor tenant position for the Purdue Technology Center's 45,000-square-foot wing, located at 3000 Kent Ave.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May